-
April 12: The Week in Cancer News
Study finds younger generations are aging faster, putting them at increased risk for cancer, and swapping the order of breast cancer treatments could improve patient care.
by Thomas Celona
-
April 5: The Week in Cancer News
More cancer patients are enrolling in clinical trials, and sentinel node biopsies alone may be adequate for some early-stage breast cancers.
by Marci A. Landsmann
-
March 29: The Week in Cancer News
Survival rates have increased for older AML patients who receive stem cell transplants, and cervical cancer diagnoses rise among women living in low-income counties.
by Kevin McLaughlin
-
March 22: The Week in Cancer News
First CAR T-cell therapy approval in chronic lymphocytic leukemia, and Environmental Protection Agency announces a complete ban on asbestos use in manufacturing.
by Thomas Celona
-
March 15: The Week in Cancer News
Modified CAR T-cell therapy shows promise in glioblastoma, and an immunotherapy may soon be available as an injection.
by Eric Fitzsimmons
-
March 8: The Week in Cancer News
Why do many Asian American women who have never smoked have lung cancer, and a report finds acne products can create cancer-causing benzine.
by Marci A. Landsmann
-
March 1: The Week in Cancer News
Many women must make decisions about preserving fertility while dealing with a cancer diagnosis, and head and neck cancer survivors face a higher stroke risk.
by Kevin McLaughlin
-
February 23: The Week in Cancer News
Melanoma drug becomes first cell therapy approved to treat a solid tumor, and a new method for treating mesothelioma extended patient survival in a recent trial.
by Thomas Celona
-
February 16: The Week in Cancer News
Researchers explore a try-everything approach to precision medicine, and physical activity may help ease cancer pain.
by Kevin McLaughlin
-
February 9: The Week in Cancer News
Patients and doctors urge researchers to study lower doses for cancer treatments, and the FDA faces criticism for not issuing a formaldehyde ban in hair straighteners.
by Marci A. Landsmann
Cancer Talk
Can Steroids Impair Immunotherapy for Cancer?
A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona